Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer.

Authors

Samuel Takvorian

Samuel U Takvorian

University of Pennsylvania, Philadelphia, PA

Samuel U Takvorian , Ravi Bharat Parikh , Daniel Vader , E. Paul Wileyto , Amy Sanders Clark , Daniel J. Lee , Gaurav Goyal , Gabrielle Betty Rocque , Efrat Dotan , Daniel M. Geynisman , Pooja Phull , Philippe E. Spiess , Roger Kim , Amy J. Davidoff , Cary Philip Gross , Rebecca A. Miksad , Gregory Sampang Calip , Lawrence N. Shulman , Ronac Mamtani , Rebecca A. Hubbard

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Care Delivery

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 1528)

DOI

10.1200/JCO.2021.39.15_suppl.1528

Abstract #

1528

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Quality Care Symposium

Impact of the COVID-19 pandemic on administration of systemic therapy in the Medicare population.

Impact of the COVID-19 pandemic on administration of systemic therapy in the Medicare population.

First Author: Peter Kardel

First Author: William D. Tap

Poster

2023 ASCO Genitourinary Cancers Symposium

Access to care and health care quality metrics in urban versus rural patients (pts) with advanced prostate cancer (aPC).

Access to care and health care quality metrics in urban versus rural patients (pts) with advanced prostate cancer (aPC).

First Author: Haoran Li

Poster

2023 ASCO Gastrointestinal Cancers Symposium

A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

First Author: Timothy J Brown